Risk of Adverse Fetal Outcomes Following Administration of a Pandemic Influenza A(H1N1) Vaccine During Pregnancy

Björn Pasternak(Phoenix Children's Hospital), Anders Hviid(Statens Serum Institut), Ditte Mølgaard‐Nielsen(Novo Nordisk (Denmark)), Mads Melbye(University of Copenhagen), Henrik Svanström(Statens Serum Institut), Tyra Grove Krause(Statens Serum Institut), Hanne‐Dorthe Emborg(Statens Serum Institut)
Obstetrical & Gynecological Survey
November 1, 2012
Cited by 10


Related Papers